10 research outputs found

    Suppl FigS3_Transmission electron microscopy of embryonic lungs

    No full text
    Analysis of the visceral pleura in a WT and nephronectin KO lung at E16.5 by transmission electron microscopy</p

    Suppl FigS1_Breeding scheme to generate KO

    No full text
    Generation of mice with the nephronectin null allele using a Pdgfrb-Cre transgenic </p

    Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain : An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake

    No full text
    Hall et al. investigated 20 inpatient adults who were exposed to ultra-processed versus unprocessed diets for 14 days each, in random order. The ultra-processed diet caused increased ad libitum energy intake and weight gain despite being matched to the unprocessed diet for presented calories, sugar, fat, sodium, fiber, and macronutrients

    Tracking the birth and growth of Cimmeria: Geochronology and origins of intrusive rocks from NW Iran

    No full text
    New geochronological and geochemical data for Late Neoproterozoic to Mesozoic intrusive rocks from NW Iran define major regional magmatic episodes and track the birth and growth of one of the Cimmerian microcontinents: the Persian block. After the final accretion of the Gondwanan terranes, the subduction of the Prototethyan Ocean beneath NW Gondwana during the Late Neoproterozoic was the trigger for high magmatic fluxes and the emplacement of isotopically diverse arc-related intrusions in NW Gondwana. The Late Neoproterozoic rocks of NW Iran belong to this magmatic event which includes intrusions with highly variable ΔHf(t) values. This magmatism continued until a magmatic lull during the Ordovician, which led to the erosion of the Neoproterozoic arc, and then was followed by a rifting event which controlled the opening of Paleotethys. In addition, it is supposed that a prolonged pulse of rift magmatism in Persia lasted from Devonian-Carboniferous to Early Permian time. These magmatic events are geographically restricted and are mostly recorded from NW Iran, although there is some evidence for these magmatic events in other segments of Iran. The Jurassic rocks of NW Iran are interpreted to be the along-strike equivalents of a Mesozoic magmatic belt (the Sanandaj-Sirjan Zone; SaSZ) toward the NW. Magmatic rocks from the SaSZ show pulsed magmatism, with high-flux events at both ~176–160 Ma and ~130 Ma. The SaSZ magmatic rocks are suggested to be formed along a continental arc but a rift setting is also considered for the formation of the SaSZ rocks based on the plume-related geochemical signatures. The arc signatures are represented by Nb-Ta depletion in the highly contaminated (by upper continental crust) plutonic rocks whereas the plume-related signature of less-contaminated melts is manifested by enrichment in Nb-Ta and high ΔHf(t) values, with peaks at +0.6 and +11.2. All these magmatic pulses led to pre-Cimmerian continental growth and reworking during the Late Neoproterozoic, rifting and detachment of the Cimmerian blocks from Gondwana in Mid-Late Paleozoic time and further crustal growth and reworking of Cimmeria during the Mesozoic.publishe

    Risk of COVID-19 after natural infection or vaccinationResearch in context

    No full text
    Summary: Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health
    corecore